SAXAGLIPTIN ANHYDROUS

SynDRA canonical compound SYN0006378 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	DPP4
Mechanism of action	Dipeptidyl peptidase inhibitor
Indication	diabetes mellitus
Disease area	endocrinology

All known targets

saxagliptin
onglyza
saxagliptin hydrochloride
saxagliptin hydrate
saxagliptin HCl
BMS 477118
BMS-477118
SBMS-477118
Saxagliptin
Onglyza
BMS-477118-11
Kombiglyze XR (TN)
OPC-262
Onglyza (TN)
(1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3
Dapagliflozin Propanediol; Saxagliptin Hydrochloride
Saxagliptin Hydrochloride
Qtern
Saxagliptin [INN]
OPC 262
8I7IO46IVQ
CHEMBL385517
CHEBI:71272
BMS477118
(1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
UNII-8I7IO46IVQ
Saxagliptine
Saxagliptin (BMS-477118,Onglyza)
HSDB 8199
NCGC00242597-01
(1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
SAXAGLIPTIN [MI]
Saxagliptin (USAN/INN)
SCHEMBL17168
SAXAGLIPTIN [WHO-DD]